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The most commonly detected mutations in BRCA1 are 185delAG
in exon 2, and 5382insC in exon 20, which have a frequency in the
Ashkenazi Jewish population of 0.9% and 0.1%, respectively
(Struewing et al, 1995; Roa et al, 1996). The 185delAG mutation
has been frequently identified in women with breast cancer who
are of Jewish ancestry (Bar-sade et al, 1998), almost always
sharing the same haplotype described in Ashkenazim, and in
different populations, including the Spanish population (Osorio et
al, 1998). The 6174delT BRCA2 mutation, in exon 11, occurs very
frequently (1.5%) among Ashkenazi Jews, but also appears in non-
Jewish individuals (Berman et al, 1996a).
Nowadays, about 80% of Jews are of Ashkenazim origin. They
originated in present day Israel, and migrated to Eastern Europe.
From the 3rd century until the end of the 15th century, Spain was
one of the main areas of settlement for Sephardic Jews (Keller,
1969). After this period, they were expelled and migrated, but
some of them remained in the Peninsula after forced conversion to
Christianity. We evaluated the prevalence of 185delAG, 5382insC
and 6174delT mutations in Spanish breast cancer patients, bearing
in mind the possible presence of Sephardic Jewish ancestors
among this population.
PATIENTS AND METHODS
We studied the 185delAG and 5382insC mutations in the BRCA1
gene in 108 families of women with breast/ovarian cancer, and 190
women regarded as sporadic cases of breast cancer, 90% of them
diagnosed between the ages of 16 and 40 years. The BRCA2
6174delT mutation was analysed in 77 of these families, and in
171 women with sporadic breast cancer.
Families were selected if they met the following criteria: three
or more close relatives with breast and/or ovarian cancer (high-
risk families), two affected relatives (moderate-risk), and one or
two second-degree affected relatives or late age of onset (low-
risk). All patients gave informed consent for testing before
providing blood samples to obtain genomic DNA.
Mutation detection was accomplished by polymerase chain
reaction (PCR), single-strand conformation polymorphism (SSCP)
and direct sequencing.
RESULTS
Only two patients with a moderate- and high-risk family history of
breast cancer showed the 185delAG BRCA1 mutation. No other
variations were detected. One patient had early-onset breast and
ovarian cancer (diagnosed at 34 years) and the other had breast and
ovarian cancer (at 51 and 55 years, respectively). In both cases the
proband￿s mother was affected with breast cancer.
Four microsatellite markers (D17S855, D17S1322, D17S1323
and D17S327) were analysed to obtain the haplotype of the
members from the two families with the mutation. In both fami-
lies, the carriers of the mutation showed the same haplotype as
reported in Ashkenazim with the 185delAG mutation (Tonin et al,
1995; Neuhausen et al, 1996). In one family, the Sephardic Jewish
origin could be confirmed by the known ancestors. We extended
this study to 20 control chromosomes and this haplotype was
absent in all of them (Table 1).
DISCUSSION
Given the presence of Jews in Spain over the centuries, we sought
to determine the frequency in the Spanish population of three
BRCA1 and BRCA2 mutations (two of them reported almost
exclusively in Ashkenazi Jewish families).
We searched for 185delAG, 5382insC and 6174delT in women
with breast and/or ovarian cancer. We found only two patients with
the 185delAG BRCA1 mutation in 108 families with a
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high/moderate-risk, which suggests an incidence of about 1.9% in
our familial cases. These results confirm the presence of the
185delAG among Spanish family members with breast cancer.
The 185delAG mutation has been found in families of
Ashkenazi and non-Ashkenazi origin almost always associated
with a common haplotype for four microsatellite markers,
although in some families of non-Jewish origin it is linked to a
different haplotype (Berman et al, 1996b; Xu et al, 1997). This
strong association suggests a ￿founder effect￿ for this mutation.
According to some authors (Neuhausen et al, 1996), the most
likely date for its origin in Ashkenazi Jews is approximately
1235 AD. In our study, the microsatellite markers delineate a
haplotype for both patients identical to the one reported in
Ashkenazi families. These results indicate a common origin of the
mutation in Spanish (Sephardic) and Ashkenazi Jewish popula-
tions. The Ashkenazi Jews moved to the Rhineland (centre of
Europe) in the 9th century, whereas the presence of Jews in Spain
can be traced back to the 3rd century. The mutation could have
appeared in the ancient Jewish genetic pool long before the diver-
gence of the two populations. This hypothesis agrees with
presence of this mutation with the same haplotype in Iraqi/Iranian
Jewish patients, who belong to the oldest Jewish community
outside Israel (Bar-Sade et al, 1998). However, it would also be
prudent to raise the possibility that the 185delAG alleles found
could have been the result of isolated admixture that occurred
since the divergence of the Sephardic and Ashkenazim Jews (at the
time of the destruction of the second Temple).
The prevalence of the BRCA2 6174delT mutation in the
Ashkenazi Jewish population is about 1.5%, and the penetrance
appears to be lower than that of 185delAG. Although we did not
find this mutation in our patients, it does not allow us to conclude
that it is not present in the Spanish population. Alternatively, it
could be suggested that the 6174delT could have emerged later in
Ashkenazi Jews, i.e. after the Sephardic Jews had already settled
in Spain.
As for the 5382insC mutation, which is recurrent in some popu-
lations, this is reported to have originated in the Baltic region
during the medieval period (38 generations ago) (Neuhausen et al,
1996). We did not detect this mutation in our patients, which could
be due to the absence of population mixing or large-scale migra-
tion from these areas to the Iberian Peninsula.
Our findings lend support to the idea that the type and frequency
of BRCA1 and BRCA2 mutations are influenced by the geograph-
ical and ethnic origins of the population studied.
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Table 1 Haplotype analysis of the two 185delAG BRCA1 mutation carriers, Ashkenazi Jewish chromosomes and Spanish control chromosomes
Alleles linked to 185delAG Alleles in
Marker Spanish Ashkenazi Jewisha
control samplesb
D17S855 7 7 3–8
D17S1322 3 3 2–6
D17S1323 3 3 2–7
D17S1327 7 6–7 2–12
aDescribed in reference: Neuhausen et al, 1996. bChromosomes studied: n = 20.